常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.76/-0.09
|
|
企業價值
17.89M
|
| 資產負債 |
|
每股賬面淨值
-0.02
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
4.94M
|
|
每股收益
--
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing the SynCardia TAH, an implantable total artificial heart system. The company is engagedin designing, manufacturing, producing, supplying, marketing, and selling medical device products, including the SynCardia TAH, which is designed to assume the full function of a failed human heart in patients suffering from advanced heartfailure. The SynCardia TAH replaces both the left and right ventricles as well as all four heart valves. |

0.1821 
